• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA28-90/I16-30
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Stretched (1601); Unintended Movement (3026)
Patient Problems Aneurysm (1708); Chest Pain (1776); Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 11/03/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
It was reported the patient had an initial procedure on (b)(6) 2014 with a bifurcated stent and an infrarenal aortic extension.On (b)(6) 2016 a follow up and computed tomography (ct) showed a decrease in overlap between the main body and the proximal extension, lateral displacement of stent by about 5mm, the graft material stretched to diameter that appears to be about 4cm, and potential aneurysm sac growth.There was no endoleak observed.Patient has not been scheduled for a secondary procedure.Patient is in stable condition.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the following reported events were confirmed; progressive loss of overlap, stretched fabric of the main body and sac growth.The reported event also indicated there was no presence of an endoleak, however, the clinical evaluation was able to confirm a type 3a endoleak.Additionally there was evidence to reasonably support the following observations; chest pain, shortness of breath, and coronary stent placement four weeks post implant.The clinical evaluation additionally found evidence to reasonably suggest the following contributing factors to the reported event; use of antiplatelet therapy, anticoagulation therapy, preexisting coronary artery disease, factor v leiden deficiency, and recent endovascular repair of an aortic aneurysm.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6148972
MDR Text Key61551553
Report Number2031527-2016-00566
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009010247
UDI-Public(01)00818009010247(17)170730
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/03/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/30/2017
Device Model NumberBA28-90/I16-30
Device Lot Number1265980-020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/07/2016
Initial Date FDA Received12/06/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/24/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/19/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
INFRARENAL AORTO UNI-ILIAC- (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-